Sofina Société Anonyme(SOF)株式概要ソフィーナ・ソシエテ・アノニムは、直接投資とファンド・オブ・ファンズ投資を専門とするプライベート・エクイティおよびベンチャー・キャピタル会社である。 詳細SOF ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績1/6財務の健全性4/6配当金2/6報酬アナリストらは、株価が31.8%上昇するだろうとほぼ一致している。 リスク分析過去5年間で収益は年間29.9%減少しました。 利益率(58.1%)は昨年より低い(94.9%) すべてのリスクチェックを見るSOF Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€223.20945.4% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-2b3b2016201920222025202620282031Revenue €35.7mEarnings €20.7mAdvancedSet Fair ValueView all narrativesSofina Société Anonyme 競合他社InfratilSymbol: NZSE:IFTMarket cap: NZ$15.9bBajaj Holdings & InvestmentSymbol: BSE:500490Market cap: ₹1.2tWHSP HoldingsSymbol: ASX:SOLMarket cap: AU$16.1bRemgroSymbol: JSE:REMMarket cap: R105.7b価格と性能株価の高値、安値、推移の概要Sofina Société Anonyme過去の株価現在の株価€223.2052週高値€284.2052週安値€204.80ベータ1.171ヶ月の変化1.18%3ヶ月変化-10.36%1年変化-10.36%3年間の変化9.09%5年間の変化-33.73%IPOからの変化63.40%最新ニュースお知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.New Risk • Mar 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).お知らせ • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.最新情報をもっと見るRecent updatesお知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.New Risk • Mar 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).お知らせ • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.お知らせ • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026お知らせ • Aug 25Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Latham & Watkins acted as legal counsel to OrganOx in this transaction.Upcoming Dividend • May 14Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Austrian dividend payers (4.9%). Lower than average of industry peers (2.8%).お知らせ • Apr 25Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million.Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million on April 24, 2025. A cash consideration valued at €34.01 per share will be paid by Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme. As part of consideration, an undisclosed value is paid towards common equity of Proeduca Altus, S.A. The proposed price for the offer is €34.01 per share, valuing the Proeduca Altus at approximately €1.536 billion. The transaction is subject to Proeduca Altus shareholders approval. Ernst & Young Transaction Advisory Services España acted as fairness opinion provider to Proeduca Altus, S.A.お知らせ • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026お知らせ • Apr 04Sofina Société Anonyme, Annual General Meeting, May 08, 2025Sofina Société Anonyme, Annual General Meeting, May 08, 2025.お知らせ • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 22% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).お知らせ • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024お知らせ • Dec 20Proofpoint, Inc. acquire Tessian Limited.Proofpoint, Inc. entered into a definitive agreement to acquire Tessian Limited on October 30, 2023. Tessian’s solutions are expected to become part of Proofpoint’s offering upon the closing of the acquisition. The acquisition is expected to close in late 2023 to early 2024, subject to customary closing conditions, including any required regulatory approvals. Piper Sandler Ltd. acted as financial advisor to Tessian Limited. Vincent Bergin, Peter Stach, P.C., Andrew Struckmeyer, David Higgins, Corey D. Fox, P.C., Bradley C. Reed, P.C., John Patten, Peter Abbott, Matthew Sinclair-Thomson, Kirsteen Nicol, Katherine C. Nemeth, Michael Falk, P.C., Sydney Jones and Jackson Phinney of Kirkland & Ellis International LLP and Kirkland & Ellis LLP acted as legal advisor to Proofpoint. The transaction is closed on December 19, 2023.Proofpoint, Inc. completed the acquisition of Tessian Limited on December 19, 2023.Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Austrian dividend payers (5.2%). Lower than average of industry peers (2.6%).Valuation Update With 7 Day Price Move • May 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €220, the stock trades at a trailing P/E ratio of 2.9x. Average trailing P/E is 10x in the Diversified Financial industry in Europe. Total returns to shareholders of 30% over the past three years.Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Austrian dividend payers (4.7%). Lower than average of industry peers (2.6%).お知らせ • May 14Sofina Reportedly in Advanced Stage of Negotiations to Lead New Funding Round in MamaearthSofina Société Anonyme (ENXTBR:SOF) is at an advanced stage of negotiations to lead a new funding round in Honasa Consumer Pvt Ltd. (Mamaearth), according to two people in the know of the matter. The fresh infusion of capital will likely value the direct-to-consumer (D2C) brand at about $700 million from around $200 million in 2020, indicating continued investor interest in D2C brands overall. Sofina is believed to have already picked up a stake in Mamaearth through a secondary share sale, a process where the money does not flow into the company directly but goes to investors selling their stakes. "There has been a recent secondary sale including from their (Mamaearth) staff as well as from Sofina which has picked up a stake. Sofina is now leading the round which will be finalised by May 2021," one of the people said on condition of anonymity. Kedaara Capital Investment Managers Limited had also held talks with Mamaearth, but it was not immediately clear whether it would participate in the new round, said two people in the know. Mamaearth's Cofounder Varun Alagh declined to comment. Sofina and Kedaara Capital did not respond to emails till press time May 13, 2021.お知らせ • Feb 04AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH on February 3, 2021. Adjust will retain its unique brand and culture and continue to operate as a distinct company. The closing of the acquisition is subject to customary (stockholder and regulatory) approvals and antitrust approval. Kris Withrow, Nancy Chen,Joseph Schenck, James Koenig, Mark Ostrau, Will Skinner and Ryan Slunaker of Fenwick & West LLP acted as legal advisors for AppLovin. Citi acted as financial advisor to AppLovin. Noerr and Paul, Weiss, Rifkind, Wharton & Garrison LLP as legal advisors for Adjust.Is New 90 Day High Low • Feb 03New 90-day high: €287The company is up 22% from its price of €235 on 04 November 2020. The Austrian market is up 35% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 17% over the same period.Is New 90 Day High Low • Dec 29New 90-day high: €276The company is up 18% from its price of €234 on 30 September 2020. The Austrian market is up 29% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 12% over the same period.Is New 90 Day High Low • Nov 17New 90-day high: €262The company is up 7.0% from its price of €244 on 19 August 2020. The Austrian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Diversified Financial industry, which is up 8.0% over the same period.Is New 90 Day High Low • Oct 29New 90-day low: €224The company is down 4.0% from its price of €234 on 30 July 2020. The Austrian market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Diversified Financial industry, which is down 1.0% over the same period.株主還元SOFAT Diversified FinancialAT 市場7D2.1%3.5%0.9%1Y-10.4%3.7%25.4%株主還元を見る業界別リターン: SOF過去 1 年間で3.7 % の収益を上げたAustrian Diversified Financial業界を下回りました。リターン対市場: SOFは、過去 1 年間で25.4 % のリターンを上げたAustrian市場を下回りました。価格変動Is SOF's price volatile compared to industry and market?SOF volatilitySOF Average Weekly Movement4.0%Diversified Financial Industry Average Movement4.4%Market Average Movement5.0%10% most volatile stocks in AT Market6.9%10% least volatile stocks in AT Market2.9%安定した株価: SOF 、 Austrian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: SOFの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。会社概要設立従業員CEO(最高経営責任者ウェブサイト189883Harold Y. Boelwww.sofinagroup.comソフィーナ・ソシエテ・アノニムは、直接投資とファンド・オブ・ファンズ投資を専門とするプライベート・エクイティおよびベンチャー・キャピタル会社である。直接投資では、グロース・キャピタル、初期投資、スタートアップ投資、後期投資、成熟投資、新興成長投資、中期投資、後期投資、LBO投資を専門としている。主に、デジタル・トランスフォーメーション、消費財・小売、教育、ヘルスケア、ライフサイエンス、持続可能なサプライチェーン、エネルギー、サービス、eコマース、消費財、デジタル、衛星事業、産業、金融会社、金融サービスに携わる世界中の企業のポートフォリオに投資している。また、メディア、通信、保険、不動産開発セクターにも投資している。通常、欧州を拠点とし、グローバルなエクスポージャーを持つ企業に投資し、特に西ヨーロッパとインド、中国、東南アジア、米国などのアジアを拠点とする企業に重点を置いている。1億ユーロ(1億308万ドル)から3億ユーロ(3億925万ドル)のマイノリティ投資を行う。2000万ユーロ(2062万ドル)から1億ユーロ(1億308万ドル)の間で、急成長中の事業への投資を目指す。500万ユーロ(535万ドル)から5,000万ユーロ(5,418万ドル)の間で、ベンチャー・キャピタルやグロース・キャピタル・ファンドへの出資を募っている。非上場企業および上場企業に投資。非上場企業に対しては、成長支援、買収資金調達、既存株主・家族への流動性提供、売却プロセス支援、支配株主と並ぶ少数株主への投資、上場企業に対しては、既存株主の代替わり、支配株主の長期的支援、上場廃止のための投資を行う。ファンド・オブ・ファンズでは、プライベート・エクイティ、ベンチャー・キャピタル、グロース・エクイティ・ファンドを中心に、バイアウトやスペシャル・シチュエーションのファンドも扱っている。また、プライベート・エクイティ・ファンドの各分野のファンドも運用している。通常、北米、米国、欧州、アジアに投資し、新興市場にも注力している。同社は、投資先企業の少数株主持分を保有することを好み、取締役会の議席を求める。マジョリティ出資や共同投資も好む。投資期間は通常10年から12年。ソフィーナ・ソシエテ・アノニムは1898年に設立され、ベルギーのブリュッセルに本社を置き、ルクセンブルク、シンガポール、英国ロンドンにオフィスを構えている。もっと見るSofina Société Anonyme 基礎のまとめSofina Société Anonyme の収益と売上を時価総額と比較するとどうか。SOF 基礎統計学時価総額€7.94b収益(TTM)€113.00m売上高(TTM)€194.37m70.2xPER(株価収益率40.8xP/SレシオSOF は割高か?公正価値と評価分析を参照収益と収入最新の決算報告書(TTM)に基づく主な収益性統計SOF 損益計算書(TTM)収益€194.37m売上原価€0売上総利益€194.37mその他の費用€81.37m収益€113.00m直近の収益報告Dec 31, 2025次回決算日Sep 02, 2026一株当たり利益(EPS)3.19グロス・マージン100.00%純利益率58.14%有利子負債/自己資本比率11.9%SOF の長期的なパフォーマンスは?過去の実績と比較を見る配当金1.6%現在の配当利回り109%配当性向View Valuation企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/05/24 23:19終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sofina Société Anonyme 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Marc DebrouwerDegroof Petercam
お知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.
お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.
New Risk • Mar 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).
お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027
New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
お知らせ • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.
お知らせ • May 22Sofina Société Anonyme announces Annual dividend, payable on May 29, 2026Sofina Société Anonyme announced Annual dividend of EUR 2.5620 per share payable on May 29, 2026, ex-date on May 27, 2026 and record date on May 28, 2026.
お知らせ • Apr 11Sofina Société Anonyme, Annual General Meeting, May 13, 2026Sofina Société Anonyme, Annual General Meeting, May 13, 2026, at 15:00 Romance Standard Time.
New Risk • Mar 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 58% Last year net profit margin: 95% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Profit margins are more than 30% lower than last year (58% net profit margin).
お知らせ • Mar 24Sofina Société Anonyme to Report Fiscal Year 2026 Results on Mar 24, 2027Sofina Société Anonyme announced that they will report fiscal year 2026 results on Mar 24, 2027
New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 25% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported June 2025 fiscal period end).
お知らせ • Oct 30Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire remaining 99.5% stake in OrganOx Limited from a group of shareholders for $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. The transaction will be funded from cash on hand and borrowings. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. The transaction is expected to close in FY2025. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Robbie McLaren, Ross McAloon, Charles Ruck, Elizabeth Richards, Betty Pang, Chad Jennings, Sean Finn, Maj Vaseghi, Kendall Burnett, Hector Armengod, Patrick English, Catherine Hein and Philipp Studt of Latham & Watkins acted as legal counsel to OrganOx in this transaction. Terumo Corporation (TSE:4543) completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders on October 29, 2025.
お知らせ • Sep 04Sofina Société Anonyme to Report First Half, 2026 Results on Sep 03, 2026Sofina Société Anonyme announced that they will report first half, 2026 results on Sep 03, 2026
お知らせ • Aug 25Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion.Terumo Corporation (TSE:4543) has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion on August 23, 2025. Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. For the period ending December 31, 2024, OrganOx Limited reported total revenue of $69.14 million and EBIT of $9.01 million. As of December 31, 2024, OrganOx Limited reported total assets of $96.9 million and total common equity of $71.56 million. The transaction is subject to approval by regulatory board / committee. Perella Weinberg Partners and Piper Sandler served as OrganOx’s financial advisors and Latham & Watkins acted as legal counsel to OrganOx in this transaction.
Upcoming Dividend • May 14Upcoming dividend of €2.45 per shareEligible shareholders must have bought the stock before 20 May 2025. Payment date: 22 May 2025. Payout ratio is a comfortable 8.6% but the company is paying out more than the cash it is generating. Trailing yield: 1.4%. Lower than top quartile of Austrian dividend payers (4.9%). Lower than average of industry peers (2.8%).
お知らせ • Apr 25Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million.Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme (ENXTBR:SOF) proposed to acquire 7.09% stake in Proeduca Altus, S.A. (BME:PRO) for approximately €110 million on April 24, 2025. A cash consideration valued at €34.01 per share will be paid by Proeduca Summa, S.L., Renta Genova, S.L., Asua Inversiones, S.L., Portobello Capital Gestión, SGEIC, S.A. and Sofina Société Anonyme. As part of consideration, an undisclosed value is paid towards common equity of Proeduca Altus, S.A. The proposed price for the offer is €34.01 per share, valuing the Proeduca Altus at approximately €1.536 billion. The transaction is subject to Proeduca Altus shareholders approval. Ernst & Young Transaction Advisory Services España acted as fairness opinion provider to Proeduca Altus, S.A.
お知らせ • Mar 27Sofina Société Anonyme to Report Fiscal Year 2025 Final Results on Mar 26, 2026Sofina Société Anonyme announced that they will report fiscal year 2025 final results on Mar 26, 2026
お知らせ • Apr 04Sofina Société Anonyme, Annual General Meeting, May 08, 2025Sofina Société Anonyme, Annual General Meeting, May 08, 2025.
お知らせ • Mar 29Sofina Société Anonyme to Report Fiscal Year 2024 Results on Mar 26, 2025Sofina Société Anonyme announced that they will report fiscal year 2024 results on Mar 26, 2025
New Risk • Mar 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 22% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end).
お知らせ • Jan 23Sofina Société Anonyme to Report First Half, 2024 Results on Sep 05, 2024Sofina Société Anonyme announced that they will report first half, 2024 results on Sep 05, 2024
お知らせ • Dec 20Proofpoint, Inc. acquire Tessian Limited.Proofpoint, Inc. entered into a definitive agreement to acquire Tessian Limited on October 30, 2023. Tessian’s solutions are expected to become part of Proofpoint’s offering upon the closing of the acquisition. The acquisition is expected to close in late 2023 to early 2024, subject to customary closing conditions, including any required regulatory approvals. Piper Sandler Ltd. acted as financial advisor to Tessian Limited. Vincent Bergin, Peter Stach, P.C., Andrew Struckmeyer, David Higgins, Corey D. Fox, P.C., Bradley C. Reed, P.C., John Patten, Peter Abbott, Matthew Sinclair-Thomson, Kirsteen Nicol, Katherine C. Nemeth, Michael Falk, P.C., Sydney Jones and Jackson Phinney of Kirkland & Ellis International LLP and Kirkland & Ellis LLP acted as legal advisor to Proofpoint. The transaction is closed on December 19, 2023.Proofpoint, Inc. completed the acquisition of Tessian Limited on December 19, 2023.
Upcoming Dividend • May 05Upcoming dividend of €2.27 per share at 1.6% yieldEligible shareholders must have bought the stock before 12 May 2023. Payment date: 16 May 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Austrian dividend payers (5.2%). Lower than average of industry peers (2.6%).
Valuation Update With 7 Day Price Move • May 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €220, the stock trades at a trailing P/E ratio of 2.9x. Average trailing P/E is 10x in the Diversified Financial industry in Europe. Total returns to shareholders of 30% over the past three years.
Upcoming Dividend • May 06Upcoming dividend of €2.19 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Payout ratio is a comfortable 4.1% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Austrian dividend payers (4.7%). Lower than average of industry peers (2.6%).
お知らせ • May 14Sofina Reportedly in Advanced Stage of Negotiations to Lead New Funding Round in MamaearthSofina Société Anonyme (ENXTBR:SOF) is at an advanced stage of negotiations to lead a new funding round in Honasa Consumer Pvt Ltd. (Mamaearth), according to two people in the know of the matter. The fresh infusion of capital will likely value the direct-to-consumer (D2C) brand at about $700 million from around $200 million in 2020, indicating continued investor interest in D2C brands overall. Sofina is believed to have already picked up a stake in Mamaearth through a secondary share sale, a process where the money does not flow into the company directly but goes to investors selling their stakes. "There has been a recent secondary sale including from their (Mamaearth) staff as well as from Sofina which has picked up a stake. Sofina is now leading the round which will be finalised by May 2021," one of the people said on condition of anonymity. Kedaara Capital Investment Managers Limited had also held talks with Mamaearth, but it was not immediately clear whether it would participate in the new round, said two people in the know. Mamaearth's Cofounder Varun Alagh declined to comment. Sofina and Kedaara Capital did not respond to emails till press time May 13, 2021.
お知らせ • Feb 04AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH.AppLovin Corporation entered into a definitive agreement to acquire adjust GmbH on February 3, 2021. Adjust will retain its unique brand and culture and continue to operate as a distinct company. The closing of the acquisition is subject to customary (stockholder and regulatory) approvals and antitrust approval. Kris Withrow, Nancy Chen,Joseph Schenck, James Koenig, Mark Ostrau, Will Skinner and Ryan Slunaker of Fenwick & West LLP acted as legal advisors for AppLovin. Citi acted as financial advisor to AppLovin. Noerr and Paul, Weiss, Rifkind, Wharton & Garrison LLP as legal advisors for Adjust.
Is New 90 Day High Low • Feb 03New 90-day high: €287The company is up 22% from its price of €235 on 04 November 2020. The Austrian market is up 35% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 17% over the same period.
Is New 90 Day High Low • Dec 29New 90-day high: €276The company is up 18% from its price of €234 on 30 September 2020. The Austrian market is up 29% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Diversified Financial industry, which is up 12% over the same period.
Is New 90 Day High Low • Nov 17New 90-day high: €262The company is up 7.0% from its price of €244 on 19 August 2020. The Austrian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Diversified Financial industry, which is up 8.0% over the same period.
Is New 90 Day High Low • Oct 29New 90-day low: €224The company is down 4.0% from its price of €234 on 30 July 2020. The Austrian market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Diversified Financial industry, which is down 1.0% over the same period.